Showing results (131-140 of 234) with videos related to
Sort By:
Pageof 24
Journal of Gastrointestinal Cancer|March 3, 2011
A rare case of metastatic pancreatic hepatoid carcinoma treated with sorafenibFausto Petrelli, Maria Ghilardi, Silvia Colombo, et al.JAMA Oncology|October 28, 2016
Prognostic Survival Associated With Left-Sided vs Right-Sided Colon Cancer: A Systematic Review and Meta-analysisFausto Petrelli, Gianluca Tomasello, Karen Borgonovo, et al.Therapeutic Advances in Medical Oncology|June 19, 2019
Major innovations and clinical applications of disodium-levofolinate: a review of available preclinical and clinical dataMargherita Ratti, Jens Claus Hahne, Laura Toppo, et al.Current Medical Research and Opinion|July 9, 2016
Burden of advanced breast cancer for patients and caregivers in Europe: comparison of two treatment forms of vinorelbine, oral and intravenousSandro Barni, Beata Freier, Isabel Garau, et al.Expert Opinion on Biological Therapy|September 6, 2012
Critical issues on high-dose chemotherapy with autologous hematopoietic progenitor cell transplantation in breast cancer patientsMassimo Martino, Alberto Bottini, Giovanni Rosti, et al.Clinical Colorectal Cancer|October 1, 2016
Efficacy and Safety of Bevacizumab Combined With Fluoropyrimidine Monotherapy for Unfit or Older Patients With Metastatic Colorectal Cancer: A Systematic Review and Meta-AnalysisCarmine Pinto, Lorenzo Antonuzzo, Luca Porcu, et al.Clinical Colorectal Cancer|June 15, 2013
FOLFIRI-bevacizumab as first-line chemotherapy in 3500 patients with advanced colorectal cancer: a pooled analysis of 29 published trialsFausto Petrelli, Karen Borgonovo, Mary Cabiddu, et al.Expert Review of Hematology|June 29, 2017
Position paper on management of iron deficiency in adult cancer patientsSandro Barni, Pere Gascòn, Fausto Petrelli, et al.Cancer|January 11, 2005
A multicenter, randomized, Phase II study of cisplatin, etoposide, and gemcitabine or cisplatin plus gemcitabine as first-line treatment in patients with poor-prognosis small cell lung carcinomaFilippo De Marinis, Fabrizio Nelli, Marco Lombardo, et al.Future Oncology (London, England)|November 10, 2018
Eribulin in the treatment of advanced breast cancer: real-world scenario from 39 Italian centers - ESEMPiO studySandro Barni, Luca Livraghi, Maria Morritti, et al.Pageof 24